nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—TRPV1—spinal nerve—peripheral nervous system neoplasm	0.073	0.224	CbGeAlD
Icosapent—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0636	0.356	CbGbCtD
Icosapent—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0625	0.349	CbGbCtD
Icosapent—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0528	0.295	CbGbCtD
Icosapent—TRPV1—sciatic nerve—peripheral nervous system neoplasm	0.0471	0.145	CbGeAlD
Icosapent—TRPV1—trigeminal nerve—peripheral nervous system neoplasm	0.0385	0.118	CbGeAlD
Icosapent—TRPV1—vagus nerve—peripheral nervous system neoplasm	0.036	0.111	CbGeAlD
Icosapent—TRPV1—cranial nerve—peripheral nervous system neoplasm	0.0274	0.0843	CbGeAlD
Icosapent—FABP7—ganglion—peripheral nervous system neoplasm	0.0153	0.0471	CbGeAlD
Icosapent—TRPV1—nerve—peripheral nervous system neoplasm	0.0141	0.0432	CbGeAlD
Icosapent—TRPV1—ganglion—peripheral nervous system neoplasm	0.0139	0.0427	CbGeAlD
Icosapent—PPARG—forelimb—peripheral nervous system neoplasm	0.0105	0.0323	CbGeAlD
Icosapent—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00913	0.727	CbGdCrCtD
Icosapent—FADS1—trigeminal ganglion—peripheral nervous system neoplasm	0.00682	0.021	CbGeAlD
Icosapent—TRPV1—trigeminal ganglion—peripheral nervous system neoplasm	0.00682	0.021	CbGeAlD
Icosapent—FABP7—brainstem—peripheral nervous system neoplasm	0.00665	0.0205	CbGeAlD
Icosapent—FADS1—parotid gland—peripheral nervous system neoplasm	0.00643	0.0198	CbGeAlD
Icosapent—ACSL4—trigeminal ganglion—peripheral nervous system neoplasm	0.00619	0.019	CbGeAlD
Icosapent—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00342	0.272	CbGdCrCtD
Icosapent—FABP7—cerebellum—peripheral nervous system neoplasm	0.00328	0.0101	CbGeAlD
Icosapent—PTGS1—ganglion—peripheral nervous system neoplasm	0.00303	0.00932	CbGeAlD
Icosapent—FADS1—cerebellum—peripheral nervous system neoplasm	0.00298	0.00915	CbGeAlD
Icosapent—ACSL4—cerebellum—peripheral nervous system neoplasm	0.0027	0.00831	CbGeAlD
Icosapent—PPARD—cerebellum—peripheral nervous system neoplasm	0.00259	0.00798	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Topotecan—peripheral nervous system neoplasm	0.00245	0.0248	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Topotecan—peripheral nervous system neoplasm	0.0024	0.0243	CcSEcCtD
Icosapent—PPARD—The citric acid (TCA) cycle and respiratory electron transport—COX2—peripheral nervous system neoplasm	0.00229	0.00596	CbGpPWpGaD
Icosapent—FFAR1—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00229	0.00596	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00229	0.00595	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—NRAS—peripheral nervous system neoplasm	0.00209	0.00543	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00207	0.00538	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—peripheral nervous system neoplasm	0.00199	0.00518	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Dactinomycin—peripheral nervous system neoplasm	0.00199	0.0201	CcSEcCtD
Icosapent—SLC8A1—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.00185	0.00481	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00184	0.00478	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0018	0.00468	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Vincristine—peripheral nervous system neoplasm	0.00177	0.0179	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00176	0.00458	CbGpPWpGaD
Icosapent—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00169	0.00439	CbGpPWpGaD
Icosapent—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.00164	0.0166	CcSEcCtD
Icosapent—FFAR1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00164	0.00426	CbGpPWpGaD
Icosapent—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.00163	0.0164	CcSEcCtD
Icosapent—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.00163	0.0164	CcSEcCtD
Icosapent—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.00159	0.00415	CbGpPWpGaD
Icosapent—SLC8A1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.00158	0.00412	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Cisplatin—peripheral nervous system neoplasm	0.00157	0.0159	CcSEcCtD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	0.00154	0.00399	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—HRAS—peripheral nervous system neoplasm	0.00153	0.00397	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00151	0.00392	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00146	0.00381	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—peripheral nervous system neoplasm	0.00146	0.00379	CbGpPWpGaD
Icosapent—PTGS2—trigeminal ganglion—peripheral nervous system neoplasm	0.00142	0.00438	CbGeAlD
Icosapent—Alanine aminotransferase increased—Etoposide—peripheral nervous system neoplasm	0.00141	0.0142	CcSEcCtD
Icosapent—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.00139	0.0141	CcSEcCtD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00139	0.00361	CbGpPWpGaD
Icosapent—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00138	0.014	CcSEcCtD
Icosapent—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00138	0.014	CcSEcCtD
Icosapent—ACSL4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00136	0.00355	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00136	0.00355	CbGpPWpGaD
Icosapent—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00134	0.0135	CcSEcCtD
Icosapent—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.0134	CcSEcCtD
Icosapent—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00133	0.0134	CcSEcCtD
Icosapent—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00131	0.0132	CcSEcCtD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—AKT1—peripheral nervous system neoplasm	0.00129	0.00335	CbGpPWpGaD
Icosapent—SLC8A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00126	0.00328	CbGpPWpGaD
Icosapent—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.0125	CcSEcCtD
Icosapent—PPARD—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.00122	0.00317	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00122	0.0123	CcSEcCtD
Icosapent—ACSL3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00122	0.00316	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00121	0.00315	CbGpPWpGaD
Icosapent—Eructation—Epirubicin—peripheral nervous system neoplasm	0.00121	0.0122	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00121	0.0122	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.0122	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00119	0.0121	CcSEcCtD
Icosapent—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00118	0.0119	CcSEcCtD
Icosapent—TRPV1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00117	0.00304	CbGpPWpGaD
Icosapent—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.0118	CcSEcCtD
Icosapent—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00117	0.0118	CcSEcCtD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00116	0.00303	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00115	0.0117	CcSEcCtD
Icosapent—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00115	0.0117	CcSEcCtD
Icosapent—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00115	0.0116	CcSEcCtD
Icosapent—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.0116	CcSEcCtD
Icosapent—Constipation—Topotecan—peripheral nervous system neoplasm	0.00114	0.0116	CcSEcCtD
Icosapent—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00113	0.0115	CcSEcCtD
Icosapent—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.0115	CcSEcCtD
Icosapent—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00113	0.0114	CcSEcCtD
Icosapent—Eructation—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.0113	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00108	0.00282	CbGpPWpGaD
Icosapent—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00105	0.0106	CcSEcCtD
Icosapent—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.0106	CcSEcCtD
Icosapent—FFAR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00104	0.0027	CbGpPWpGaD
Icosapent—FADS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00102	0.00265	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00101	0.00263	CbGpPWpGaD
Icosapent—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.0102	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000988	0.00999	CcSEcCtD
Icosapent—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000969	0.0098	CcSEcCtD
Icosapent—PPARD—Presenilin action in Notch and Wnt signaling—MYC—peripheral nervous system neoplasm	0.000962	0.0025	CbGpPWpGaD
Icosapent—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000946	0.00957	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000943	0.00245	CbGpPWpGaD
Icosapent—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000942	0.00952	CcSEcCtD
Icosapent—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000939	0.00949	CcSEcCtD
Icosapent—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000939	0.00949	CcSEcCtD
Icosapent—PPARD—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000934	0.00243	CbGpPWpGaD
Icosapent—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000926	0.00937	CcSEcCtD
Icosapent—ACSL4—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000921	0.0024	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000921	0.0024	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000916	0.00926	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000904	0.00235	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.00089	0.00232	CbGpPWpGaD
Icosapent—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000885	0.00895	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000883	0.00892	CcSEcCtD
Icosapent—ACSL3—Metabolism—GNS—peripheral nervous system neoplasm	0.000879	0.00229	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000868	0.00878	CcSEcCtD
Icosapent—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00086	0.00869	CcSEcCtD
Icosapent—PTGS2—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.000857	0.00223	CbGpPWpGaD
Icosapent—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000857	0.00866	CcSEcCtD
Icosapent—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00085	0.0086	CcSEcCtD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000847	0.0022	CbGpPWpGaD
Icosapent—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000843	0.00853	CcSEcCtD
Icosapent—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000843	0.00853	CcSEcCtD
Icosapent—Rash—Topotecan—peripheral nervous system neoplasm	0.000843	0.00853	CcSEcCtD
Icosapent—ACSL3—Metabolism—NME1—peripheral nervous system neoplasm	0.000843	0.00219	CbGpPWpGaD
Icosapent—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000842	0.00852	CcSEcCtD
Icosapent—Rash—Tretinoin—peripheral nervous system neoplasm	0.000836	0.00846	CcSEcCtD
Icosapent—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000836	0.00846	CcSEcCtD
Icosapent—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000836	0.00846	CcSEcCtD
Icosapent—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000836	0.00845	CcSEcCtD
Icosapent—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000836	0.00845	CcSEcCtD
Icosapent—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000833	0.00842	CcSEcCtD
Icosapent—Constipation—Vincristine—peripheral nervous system neoplasm	0.000828	0.00838	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000826	0.00215	CbGpPWpGaD
Icosapent—Rash—Melphalan—peripheral nervous system neoplasm	0.000826	0.00835	CcSEcCtD
Icosapent—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000825	0.00834	CcSEcCtD
Icosapent—ACSL3—Metabolism—COX2—peripheral nervous system neoplasm	0.000811	0.00211	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000806	0.00815	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000789	0.00798	CcSEcCtD
Icosapent—FFAR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000787	0.00205	CbGpPWpGaD
Icosapent—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000785	0.00793	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00078	0.00789	CcSEcCtD
Icosapent—PPARD—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000767	0.002	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000766	0.00199	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—MET—peripheral nervous system neoplasm	0.000759	0.00198	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.00754	CcSEcCtD
Icosapent—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00074	0.00748	CcSEcCtD
Icosapent—FADS1—Metabolism—GNS—peripheral nervous system neoplasm	0.000737	0.00192	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000735	0.00191	CbGpPWpGaD
Icosapent—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00073	0.00739	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000722	0.00188	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000715	0.00186	CbGpPWpGaD
Icosapent—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000711	0.00719	CcSEcCtD
Icosapent—FADS1—Metabolism—NME1—peripheral nervous system neoplasm	0.000706	0.00184	CbGpPWpGaD
Icosapent—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000689	0.00697	CcSEcCtD
Icosapent—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000684	0.00691	CcSEcCtD
Icosapent—SLC8A1—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000681	0.00177	CbGpPWpGaD
Icosapent—FADS1—Metabolism—COX2—peripheral nervous system neoplasm	0.00068	0.00177	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000677	0.00685	CcSEcCtD
Icosapent—Constipation—Etoposide—peripheral nervous system neoplasm	0.000671	0.00679	CcSEcCtD
Icosapent—FFAR1—Metabolism—GNS—peripheral nervous system neoplasm	0.000666	0.00173	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—GNS—peripheral nervous system neoplasm	0.000666	0.00173	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—EED—peripheral nervous system neoplasm	0.000666	0.00173	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000662	0.00172	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000659	0.00172	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00065	0.00169	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000641	0.00167	CbGpPWpGaD
Icosapent—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000639	0.00646	CcSEcCtD
Icosapent—FFAR1—Metabolism—NME1—peripheral nervous system neoplasm	0.000639	0.00166	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—NME1—peripheral nervous system neoplasm	0.000639	0.00166	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000635	0.00165	CbGpPWpGaD
Icosapent—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000634	0.00641	CcSEcCtD
Icosapent—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000633	0.0064	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.000629	0.00164	CbGpPWpGaD
Icosapent—PTGS2—cerebellum—peripheral nervous system neoplasm	0.000621	0.00191	CbGeAlD
Icosapent—TRPV1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000619	0.00161	CbGpPWpGaD
Icosapent—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000616	0.00623	CcSEcCtD
Icosapent—ACSL4—Metabolism—COX2—peripheral nervous system neoplasm	0.000615	0.0016	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—COX2—peripheral nervous system neoplasm	0.000615	0.0016	CbGpPWpGaD
Icosapent—Rash—Vincristine—peripheral nervous system neoplasm	0.000611	0.00618	CcSEcCtD
Icosapent—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00061	0.00617	CcSEcCtD
Icosapent—SLC8A1—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000596	0.00155	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000586	0.00153	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—CDKN2A—peripheral nervous system neoplasm	0.00058	0.00151	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—HGF—peripheral nervous system neoplasm	0.000568	0.00148	CbGpPWpGaD
Icosapent—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.00056	0.00146	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000557	0.00145	CbGpPWpGaD
Icosapent—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000555	0.00561	CcSEcCtD
Icosapent—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000545	0.00551	CcSEcCtD
Icosapent—Rash—Cisplatin—peripheral nervous system neoplasm	0.00054	0.00546	CcSEcCtD
Icosapent—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00054	0.00546	CcSEcCtD
Icosapent—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000539	0.00545	CcSEcCtD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000535	0.00139	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000534	0.00139	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—ENO2—peripheral nervous system neoplasm	0.000533	0.00139	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000532	0.00139	CbGpPWpGaD
Icosapent—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000528	0.00534	CcSEcCtD
Icosapent—PPARD—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000518	0.00135	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000516	0.00134	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—peripheral nervous system neoplasm	0.000509	0.00132	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000508	0.00132	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000506	0.00132	CbGpPWpGaD
Icosapent—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000499	0.00504	CcSEcCtD
Icosapent—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000499	0.00504	CcSEcCtD
Icosapent—TRPV1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000498	0.0013	CbGpPWpGaD
Icosapent—Rash—Etoposide—peripheral nervous system neoplasm	0.000495	0.005	CcSEcCtD
Icosapent—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000494	0.005	CcSEcCtD
Icosapent—TRPV1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000489	0.00127	CbGpPWpGaD
Icosapent—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.00494	CcSEcCtD
Icosapent—PPARG—Wnt Signaling Pathway Netpath—MYC—peripheral nervous system neoplasm	0.000476	0.00124	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000467	0.00121	CbGpPWpGaD
Icosapent—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000459	0.00464	CcSEcCtD
Icosapent—PPARG—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000452	0.00118	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—BCHE—peripheral nervous system neoplasm	0.00045	0.00117	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000446	0.00116	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000445	0.00116	CbGpPWpGaD
Icosapent—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00445	CcSEcCtD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00043	0.00112	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000429	0.00112	CbGpPWpGaD
Icosapent—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.00429	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000424	0.0011	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—TH—peripheral nervous system neoplasm	0.000423	0.0011	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000422	0.0011	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000419	0.00109	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—peripheral nervous system neoplasm	0.000418	0.00109	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000414	0.00108	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000408	0.00106	CbGpPWpGaD
Icosapent—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.00412	CcSEcCtD
Icosapent—FFAR1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000404	0.00105	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ENO2—peripheral nervous system neoplasm	0.000404	0.00105	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000401	0.00405	CcSEcCtD
Icosapent—PPARD—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	0.000399	0.00104	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000391	0.00102	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00039	0.00101	CbGpPWpGaD
Icosapent—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000387	0.00392	CcSEcCtD
Icosapent—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00384	CcSEcCtD
Icosapent—FADS1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000377	0.000981	CbGpPWpGaD
Icosapent—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000376	0.0038	CcSEcCtD
Icosapent—PPARD—Metabolism—GNS—peripheral nervous system neoplasm	0.000374	0.000974	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.00375	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000371	0.000964	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—EED—peripheral nervous system neoplasm	0.000364	0.000946	CbGpPWpGaD
Icosapent—FADS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00036	0.000936	CbGpPWpGaD
Icosapent—PPARD—Metabolism—NME1—peripheral nervous system neoplasm	0.000359	0.000934	CbGpPWpGaD
Icosapent—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.00362	CcSEcCtD
Icosapent—FADS1—Metabolism—TH—peripheral nervous system neoplasm	0.000355	0.000923	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000353	0.000919	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.000352	0.000917	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.00355	CcSEcCtD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.00035	0.00091	CbGpPWpGaD
Icosapent—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.00352	CcSEcCtD
Icosapent—PPARD—Metabolism—COX2—peripheral nervous system neoplasm	0.000346	0.000899	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—GNAS—peripheral nervous system neoplasm	0.000345	0.000899	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—BCHE—peripheral nervous system neoplasm	0.000341	0.000887	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000341	0.000887	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000339	0.000882	CbGpPWpGaD
Icosapent—PPARG—Wnt Signaling Pathway Netpath—AKT1—peripheral nervous system neoplasm	0.00033	0.000859	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000325	0.000847	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000325	0.000847	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—TH—peripheral nervous system neoplasm	0.000321	0.000834	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—TH—peripheral nervous system neoplasm	0.000321	0.000834	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000318	0.000826	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000313	0.000816	CbGpPWpGaD
Icosapent—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000311	0.00315	CcSEcCtD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000298	0.000777	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000293	0.000763	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000293	0.000761	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000292	0.00076	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000291	0.000756	CbGpPWpGaD
Icosapent—FADS1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000289	0.000753	CbGpPWpGaD
Icosapent—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.00291	CcSEcCtD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000287	0.000747	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000284	0.000739	CbGpPWpGaD
Icosapent—PPARG—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000283	0.000736	CbGpPWpGaD
Icosapent—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00028	0.00283	CcSEcCtD
Icosapent—Rash—Epirubicin—peripheral nervous system neoplasm	0.000277	0.0028	CcSEcCtD
Icosapent—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000277	0.0028	CcSEcCtD
Icosapent—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000266	0.000693	CbGpPWpGaD
Icosapent—PPARG—SREBP signalling—AKT1—peripheral nervous system neoplasm	0.000263	0.000685	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000262	0.000681	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000262	0.000681	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—GNAS—peripheral nervous system neoplasm	0.000262	0.000681	CbGpPWpGaD
Icosapent—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00262	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000257	0.00067	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000257	0.000668	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000257	0.000668	CbGpPWpGaD
Icosapent—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.00259	CcSEcCtD
Icosapent—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.00259	CcSEcCtD
Icosapent—FFAR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00025	0.000651	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000249	0.000648	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.00024	0.000624	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000239	0.000621	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000236	0.000613	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000235	0.000611	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000233	0.000606	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000229	0.000597	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ENO2—peripheral nervous system neoplasm	0.000227	0.00059	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000219	0.00057	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GNS—peripheral nervous system neoplasm	0.000204	0.000532	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000198	0.000515	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NME1—peripheral nervous system neoplasm	0.000196	0.00051	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000194	0.000504	CbGpPWpGaD
Icosapent—PPARD—Metabolism—BCHE—peripheral nervous system neoplasm	0.000192	0.000499	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—TP53—peripheral nervous system neoplasm	0.00019	0.000496	CbGpPWpGaD
Icosapent—PPARG—Metabolism—COX2—peripheral nervous system neoplasm	0.000189	0.000491	CbGpPWpGaD
Icosapent—PPARD—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000183	0.000476	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000182	0.000474	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.00018	0.000469	CbGpPWpGaD
Icosapent—PPARD—Metabolism—TH—peripheral nervous system neoplasm	0.00018	0.000469	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000176	0.000458	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000165	0.000428	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000161	0.000418	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000157	0.000409	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000155	0.000403	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000153	0.000398	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000152	0.000396	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MET—peripheral nervous system neoplasm	0.000152	0.000395	CbGpPWpGaD
Icosapent—PPARD—Metabolism—GNAS—peripheral nervous system neoplasm	0.000147	0.000383	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000144	0.000376	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	0.000143	0.000373	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000142	0.000369	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.00014	0.000365	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000137	0.000358	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	0.000137	0.000357	CbGpPWpGaD
Icosapent—PTGS2—Disease—GNS—peripheral nervous system neoplasm	0.000136	0.000353	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000133	0.000345	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	0.000132	0.000344	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000132	0.000343	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000131	0.00034	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ENO2—peripheral nervous system neoplasm	0.000124	0.000322	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00012	0.000313	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.00012	0.000312	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	0.000114	0.000296	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000113	0.000295	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000113	0.000294	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000111	0.000289	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.00011	0.000287	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000109	0.000284	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	0.000109	0.000284	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	0.000105	0.000273	CbGpPWpGaD
Icosapent—PPARG—Metabolism—BCHE—peripheral nervous system neoplasm	0.000105	0.000272	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.0001	0.00026	CbGpPWpGaD
Icosapent—PPARG—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.98e-05	0.00026	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TH—peripheral nervous system neoplasm	9.84e-05	0.000256	CbGpPWpGaD
Icosapent—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	9.49e-05	0.000247	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.35e-05	0.000243	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—AKT1—peripheral nervous system neoplasm	9.32e-05	0.000243	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.15e-05	0.000238	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	8.68e-05	0.000226	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.52e-05	0.000222	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.44e-05	0.00022	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	8.35e-05	0.000217	CbGpPWpGaD
Icosapent—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	8.22e-05	0.000214	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GNAS—peripheral nervous system neoplasm	8.03e-05	0.000209	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ABCB1—peripheral nervous system neoplasm	7.88e-05	0.000205	CbGpPWpGaD
Icosapent—FADS1—Metabolism—AKT1—peripheral nervous system neoplasm	7.81e-05	0.000203	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.68e-05	0.0002	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MYC—peripheral nervous system neoplasm	7.36e-05	0.000192	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	7.33e-05	0.000191	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—AKT1—peripheral nervous system neoplasm	7.07e-05	0.000184	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—AKT1—peripheral nervous system neoplasm	7.07e-05	0.000184	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7e-05	0.000182	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.99e-05	0.000182	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	6.89e-05	0.000179	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	6.89e-05	0.000179	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.69e-05	0.000174	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	6.63e-05	0.000173	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.48e-05	0.000169	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.17e-05	0.000161	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.91e-05	0.000154	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	5.82e-05	0.000151	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	5.63e-05	0.000146	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.55e-05	0.000144	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.52e-05	0.000144	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	5.47e-05	0.000142	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.45e-05	0.000142	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—AKT1—peripheral nervous system neoplasm	5.11e-05	0.000133	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	4.47e-05	0.000116	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.38e-05	0.000114	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MYC—peripheral nervous system neoplasm	4.02e-05	0.000105	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AKT1—peripheral nervous system neoplasm	3.97e-05	0.000103	CbGpPWpGaD
Icosapent—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	3.71e-05	9.65e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	2.93e-05	7.62e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—AKT1—peripheral nervous system neoplasm	2.79e-05	7.26e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	2.23e-05	5.8e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKT1—peripheral nervous system neoplasm	2.17e-05	5.64e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MYC—peripheral nervous system neoplasm	2.08e-05	5.4e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	1.63e-05	4.24e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	1.52e-05	3.95e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	1.44e-05	3.75e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	1.21e-05	3.14e-05	CbGpPWpGaD
